Rhabdomyosarcoma
📧 Sign up to get email alerts when something new happens for Rhabdomyosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma [NA]
This clinical trial update notes the completion of a pediatric rhabdomyosarcoma study evaluating proton radiation therapy, with results post…
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial [Phase 2]
Phase 2 pediatric MATCH trial results for Tipifarnib in HRAS-altered solid tumors and histiocytic disorders; the study has posted results an…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Collecting and Storing Tissue From Young Patients With Cancer
A completed clinical trial update from the Children’s Oncology Group describing the collection and storage of tissue from pediatric cancer p…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma [EARLY_Phase 1]
An exploratory early-phase study evaluating a personalized mRNA vaccine in patients with refractory rhabdomyosarcoma.
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of First Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study [Phase 2]
A Phase II randomized trial in children with first-relapsed and refractory rhabdomyosarcoma compares Doxorubicin liposome plus Irinotecan (A…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry
This clinical trial update notes ongoing recruitment for a study in pediatric, adolescent, and young adult rhabdomyosarcoma using spatial pr…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor [Phase 1]
Phase 1 trial evaluating a conditioning regimen of busulfan, melphalan, and topotecan hydrochloride followed by stem cell transplantation in…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors [Phase 2]
Phase 2 trial update of haploidentical transplantation with donor natural killer cells for solid tumors; the study was terminated and result…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) [NA]
This entry reports on the MICCHADO trial, which investigates the biological characterization of high-risk childhood cancers. The sponsor is …
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Radiation Therapy to Treat Musculoskeletal Tumors [Phase 2]
A Phase 2 clinical trial evaluating radiation therapy for musculoskeletal tumors has posted results (as of 2025-03-06). The study is current…
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma [Phase 1, Phase 2]
A phase 1/2 trial evaluating the combination of prexasertib, irinotecan, and temozolomide in Desmoplastic Small Round Cell Tumor and rhabdom…
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients [EARLY_Phase 1]
Early-phase 1 clinical trial evaluating heated intraperitoneal chemotherapy with doxorubicin and cisplatin for pediatric abdominal/pelvic tu…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors. [Phase 3]
A Phase 3 prospective cohort trial is evaluating risk-factor-based, stratified treatment for rhabdomyosarcoma and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models
A clinical trial from Xinhua Hospital and Shanghai Jiao Tong University aims to improve diagnosis and grading of pediatric solid tumors usin…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents [Phase 2]
Phase 2 clinical trial evaluating pazopanib in combination with TGI/CIV for recurrent or refractory rhabdomyosarcoma in children and adolesc…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases [NA]
Clinical trial update indicates completion of a study evaluating intensity-modulated radiation therapy in younger patients with lung metasta…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors [Phase 2]
Phase 2 pediatric trial evaluating palbociclib in combination with chemotherapy for recurrent or refractory solid tumors, including Ewing sa…
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors [Phase 2]
Phase 2 trial evaluating neoadjuvant dual checkpoint inhibition with cryoablation in relapsed/refractory pediatric solid tumors has complete…
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors [Phase 1]
Phase 1 trial completion evaluating MR-guided High Intensity Focused Ultrasound (HIFU) for relapsed or refractory pediatric solid tumors, in…
-
CLINICAL_TRIALS withdrawal · 2025-01-01Clinical Trial Update: A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors [Phase 2]
A Phase 2 pilot study evaluating Thermodox in combination with MR-HIFU for relapsed solid tumors has been withdrawn.
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors [Phase 2]
Phase II, multi-cohort, single-arm trial evaluating a triplet regimen of albumin-bound paclitaxel, ifosfamide, and cisplatin in rare advance…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas [Phase 1]
ClinicalTrials.gov entry describing a Phase 1 study of molecular-functional imaging of hypoxia in childhood sarcomas, currently enrolling by…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision) [Phase 1, Phase 2]
Phase 1/2 clinical trial update for PerVision, a personalized cancer vaccine for fusion-positive sarcomas, currently recruiting at Universit…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma [Phase 3]
Phase 3 trial evaluating adding temsirolimus to combination chemotherapy for intermediate-risk rhabdomyosarcoma; results posted in 2024 and …
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma [Phase 3]
Phase 3 trial examining combination chemotherapy with or without temsirolimus in intermediate-risk rhabdomyosarcoma; active/not recruiting w…